Congressional Budget Office analysts say that Medicaid unwinding, immigration and scheduled end of ACA premium subsidies are ...

A recent industry survey conducted by HealthEdge provides insight into how health insurance consumers in the United States ...

In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with board member, Eric Hunter ...

The recent DUO trial, a global Phase III study, compared the efficacy and safety of duvelisib, an oral PI3K inhibitor, with ...

Researchers suggest younger people with diabetes need more education and better support to manage their diabetes. Despite ...

The same is not true for Black women, who are 40% more likely to die from breast cancer than white women, suggesting other ...

A study in mice, researchers at the University of Michigan have found infection with RSV can alter lung function in young ...

A new study published May 2024 in Scientific Reports examined the changes in morphology and antibacterial activity in four ...

Farxiga (dapagliflozin) has been approved by the FDA to treat type-2 diabetes patients ages 10 and older, AstraZeneca ...

Researchers completed a phase 2 clinical trial investigating the use of autologous stem cell-derived neural progenitors as a ...

The science of pulmonary arterial hypertension (PAH) has advanced significantly in recent years. However, as the push for new ...

A recent study of children with RSV conducted by St. Jude faculty member M. Asunción Mejías, M.D., Ph.D., and colleagues ...